Personal information
Verified email addresses
Verified email domains
Biography
My interests lie at the intersection of computational structural biology and artificial intelligence.
At the university, I decided that science is more important to me than taking classes, so I devoted most of my time and energy to research. From 2018 to 2021 I worked in the Virtual Structural Biology Group to study cardiovascular diseases. There I learned molecular modeling and structural biology of proteins and nucleic acids. In 2020 I decided to expand my horizons to Alzheimer's disease and started to investigate the effect of ions on the aggregation of amyloid fibrils in the Strodel lab at Forschungszentrum Jülich IBI-7. Since 2021, I joined Victor Greiff’s lab in Oslo, where I am working on antibody developability and modeling benchmarking projects on computational structural immunology and antibody design. At the same time, I started to work with Shuguang Zhang at the Laboratory of Molecular Architecture at MIT, where I am investigating water-soluble membrane proteins using various bioinformatician methods. Later that year I became a member of Sergey Ovchinnikov's lab at Harvard, where I am studying AlphaFold2 in the contest of protein de novo design. Aiming to open my own drug design startup in the future, I joined Biosim.AI in 2022 to boost my industrial skills. There I learned how biotech companies combined MD, AI, and quantum chemistry to accelerate the drug design process.